FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda. The U.S. Food and Drug Administration (FDA) has ...
The Cancer Action Plan of Washington, or CAPOW, a five-year strategic plan to reduce cancer rates — and cancer deaths — in Washington state just dropped. What action is Fred Hutch taking to drop ...
Cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) programs are often limited to centers in developed countries because of extensive requirements. We aimed to analyze efficacy ...
Real-world performance and clinical outcome of comprehensive genomic profiling of gastrointestinal tumors: High-volume, single-center experience. Unveiling prognosis and traits of dMMR/MSI-H gastric ...
What is the cause of this patient's severe, painful ascites? Painful, severe ascites can be due to peritoneal diseases such as malignancy or tuberculosis. In such cases, however, the peritoneal fluid ...
Combined epigenetic and immune checkpoint therapy altered the tumour microenvironment in platinum-resistant ovarian cancer.
Icodextrin use in peritoneal dialysis patients with congestive heart failure (CHF) is associated with better survival and cardiovascular outcomes compared with nonuse, according to a target trial ...
Dear Dr. Roach: My husband is 81 and in good health. He doesn’t have any blood in his urine or any other abnormal symptoms. He recently had an X-ray done for lower back pain, and the radiologist ...
Cancer usually comes with a heavy sense of fear. For many patients, it means repeated hospital visits, exhausting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results